Pages that link to "Q81515020"

The following pages link to The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow oedema in patients with psoriatic arthritis (Q81515020):

Displaying 30 items.

• Altered bone remodeling in psoriatic arthritis (Q28288855) (← links)
• Quantification of bone marrow lesion volume and volume change using semi-automated segmentation: data from the osteoarthritis initiative (Q30584019) (← links)
• RANKL induces heterogeneous DC-STAMP(lo) and DC-STAMP(hi) osteoclast precursors of which the DC-STAMP(lo) precursors are the master fusogens (Q33624650) (← links)
• Quantitative bone marrow lesion size in osteoarthritic knees correlates with cartilage damage and predicts longitudinal cartilage loss (Q34035937) (← links)
• Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion (Q34153144) (← links)
• Biomarkers to Diagnose Early Arthritis in Patients With Psoriasis. (Q34563661) (← links)
• Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions (Q36353577) (← links)
• The Peripheral Blood Mononuclear Cell Count Is Associated With Bone Health in Elderly Men: A Cross-Sectional Population-Based Study (Q36822454) (← links)
• Juvenile idiopathic arthritis: clinically relevant imaging in diagnosis and monitoring (Q37159227) (← links)
• MRI in psoriatic arthritis: insights into pathogenesis and treatment response (Q37228838) (← links)
• The diagnosis and treatment of early psoriatic arthritis. (Q37608918) (← links)
• Lead discovery, chemistry optimization, and biological evaluation studies of novel biamide derivatives as CB2 receptor inverse agonists and osteoclast inhibitors (Q37668664) (← links)
• Novel triaryl sulfonamide derivatives as selective cannabinoid receptor 2 inverse agonists and osteoclast inhibitors: discovery, optimization, and biological evaluation (Q37668713) (← links)
• Update on biomarkers in psoriatic arthritis (Q37741049) (← links)
• Imaging in psoriatic arthritis (Q37980390) (← links)
• Altered bone biology in psoriatic arthritis (Q38010645) (← links)
• Arthritis mutilans (Q38083619) (← links)
• Psoriatic arthritis: recent progress in pathophysiology and drug development. (Q38194559) (← links)
• TNF and Bone Remodeling (Q39287117) (← links)
• The role of bone marrow edema and lymphangiogenesis in inflammatory-erosive arthritis (Q41973199) (← links)
• Synovial effusion and synovial fluid biomarkers in psoriatic arthritis to assess intraarticular tumor necrosis factor-α blockade in the knee joint. (Q42420342) (← links)
• Study of drug function based on similarity of pathway fingerprint (Q42566617) (← links)
• Altered Bone Remodeling in Psoriatic Disease: New Insights and Future Directions (Q47734526) (← links)
• Strategies for Biomarker Development in Psoriatic Disease: A Report from the GRAPPA 2010 Annual Meeting (Q48739015) (← links)
• MRI of psoriatic nail disease pre- and post-TNF inhibitor therapy shows persistent subclinical inflammation after 6 months despite good clinical response. (Q52802892) (← links)
• Mechanisms of Bone Remodelling in Psoriatic Arthritis (Q57673007) (← links)
• What Are the Peripheral Blood Determinants for Increased Osteoclast Formation in the Various Inflammatory Diseases Associated With Bone Loss? (Q64075123) (← links)
• [Cross-sectional imaging of peripheral involvement in psoriatic arthritis] (Q83155696) (← links)
• [Spondyloarthritis and quality of life] (Q83825065) (← links)
• Does TNF Promote or Restrain Osteoclastogenesis and Inflammatory Bone Resorption? (Q91921619) (← links)